Squarepoint Ops LLC Geo Vax Labs, Inc. Transaction History

Squarepoint Ops LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$52.65 - $71.7 $616,320 - $839,320	-11,706 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$56.4 - $91.35 $660,218 - $1.07 Million	11,706 New	11,706 $51,000
Q2 2021 Aug 16, 2021	SELL	$64.8 - $94.5 $682,538 - $995,368	-10,533 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$49.05 - $126.6 $516,643 - $1.33 Million	10,533 New	10,533 $46,000

Ticker GOVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,744,000
Market Cap $51.2M
Description
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhag...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.